Nigeria has evacuated its first confirmed Ebola patient abroad for further medical treatment as health authorities intensify efforts to prevent the spread of the Bundibugyo strain of the virus.
The 42-year-old woman was flown from Abuja to Switzerland early on Monday, October 26, 2026, aboard a medical evacuation aircraft after receiving treatment in Nigeria, according to the Federal Government.
Coordinating Minister of Health and Social Welfare Muhammad Ali Pate confirmed that the patient had clinically improved and was stable, conscious and able to communicate at the time of her evacuation.
The patient, who is married to a Swiss diplomat, travelled alongside her husband, who remained asymptomatic, while strict medical and public health protocols were implemented for the transfer.
The evacuation took place through the private aviation section of the Nnamdi Azikiwe International Airport in Abuja, where an ambulance convoy transported the patient from the city centre to the aircraft.
The operation comes amid heightened surveillance and contact-tracing activities following Nigeria’s confirmation of an imported case of Ebola virus disease caused by the Bundibugyo virus.
Health authorities have identified 53 contacts linked to the confirmed case, including healthcare workers, domestic staff and the patient’s spouse, with public health teams continuing to assess and monitor those who may have been exposed.
Officials have emphasised that the patient’s improved condition does not automatically mean she is no longer infectious, making the strict observance of infection prevention measures essential throughout the evacuation and subsequent care.
The Nigeria Centre for Disease Control and Prevention has said that contacts are being followed up for 21 days from their last possible exposure, in line with the national response to the outbreak.
The monitoring process is intended to identify possible infections early, provide appropriate guidance to exposed individuals and prevent further transmission if another case emerges.
The patient reportedly returned to Nigeria from Uganda through Addis Ababa on October 3, 2026, and developed symptoms four days after arriving in the country.
She subsequently sought medical attention at private healthcare facilities in Abuja before the NCDC was notified and laboratory investigations confirmed the infection on October 20.
Symptoms reported at presentation included fever, diarrhoea, generalised body aches and a sore throat, while bleeding was not reported in the initial case information released by health authorities.
The World Health Organization confirmed that Nigeria’s case involved the Bundibugyo virus, a species of Ebola virus associated with outbreaks in parts of Africa, and said it was supporting Nigerian authorities with case investigation, contact tracing, infection prevention and control measures.
The WHO has stressed the importance of early detection, monitoring of exposed individuals and appropriate protective measures in healthcare facilities to limit the risk of further infections.
Nigeria’s public health response has involved the Federal Ministry of Health and Social Welfare, the NCDC, the Federal Capital Territory health authorities and international partners working to coordinate surveillance, clinical care and risk communication.
NCDC Director-General Jide Idris has urged healthcare facilities to strengthen screening and triage, maintain appropriate infection prevention standards and promptly isolate and report suspected cases instead of waiting for laboratory confirmation before taking precautions.
The agency has also appealed to members of the public to cooperate with contact-tracing teams, provide accurate information about possible exposure and rely on official health updates rather than circulate unverified claims.
Authorities have warned against stigmatising patients, their families, healthcare workers or people identified as contacts, noting that being monitored does not mean an individual has contracted Ebola.
The evacuation follows earlier concern about the patient’s condition, which had been described by officials as severe during the initial stages of her treatment in Nigeria.
Her subsequent clinical improvement is encouraging, but health authorities continue to treat the situation seriously because recovery in a patient does not by itself establish that the risk of transmission has ended.
The government is expected to continue providing updates as the medical transfer progresses and contact-tracing investigations produce further findings.
For now, the priorities remain ensuring the patient receives appropriate care, protecting medical personnel, completing the monitoring of identified contacts and preventing additional infections.
Nigeria’s experience managing an Ebola outbreak in 2014 provides public health authorities with previous lessons in surveillance, rapid response, contact tracing and public cooperation, all of which remain central to the current containment effort.